Putnam Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-27,970
Closed -$562K 1333
2017
Q1
$562K Sell
27,970
-18,534
-40% -$372K ﹤0.01% 1091
2016
Q4
$725K Buy
+46,504
New +$725K ﹤0.01% 1068